← Back to catalogue

RELISA® ANA Screening Test System

FDA UDI

by Immuno Concepts Inc

Identity

Trade Name
RELISA® ANA Screening Test System FDA UDI
Generic Name
Multiple antinuclear antibody (ANA) screening IVD, kit, enzyme immunoassay (EIA) FDA UDI
Device Name
RELISA® ANA Test System - 96 Wells FDA UDI
Model / Reference
7096-11 FDA UDI
Description
RELISA® ANA Test System - 96 Wells FDA UDI

Identifiers

Catalog Number
7096-11 FDA UDI
Primary DI / UDI-DI
M7497096111 FDA UDI
GMDN Term
Multiple antinuclear antibody (ANA) screening IVD, kit, enzyme immunoassay (EIA) FDA UDI

Classification

Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Multiple antinuclear antibody (ANA) screening IVD, kit, enzyme immunoassay (EIA)

RELISA® ANA Screening Test System by Immuno Concepts Inc — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Multiple antinuclear antibody (ANA) screening IVD, kit, enzyme immunoassay (EIA).

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Immuno Concepts Inc

Sources (1)

  • FDA UDI f47bf38b-56f9-47c3-a64a-84db8aadca29 34 fields · synced Jun 1, 2026